Atopy and viral infections von Resiliac, Jenny, Grayson, Mitchell H.

Volltext

Atopy and viral infections Could polyomaviruses be to blame? von Resiliac, Jenny, Grayson, Mitchell H.

Volltext

Lipopolysaccharide pre-treatment prevents viral induced death by priming macrophages for a robust anti-viral immune response von Resiliac, Jenny, Rohlfing, Michelle, Santoro, Jennifer, Hussain, Syed-Rehan A, Grayson, Mitchell H

Volltext

Pre-existing atopy prevents mortality from respiratory viral infection via induction of neuregulin-1 von Hussain, Syed-Rehan A, Rohlfing, Michelle, Santoro, Jennifer, Resiliac, Jenny, Grayson, Mitchell H

Volltext

Lipopolysaccharide (LPS) pre-treatment skews the cytokine milieu early during the infection to prevent airway hyperresponsiveness von Resiliac, Jenny, Rohlfing, Michelle, Santoro, Jennifer, Hussain, Syed-Rehan, Grayson, Mitchell

Volltext

The effect of lipopolysaccharide (LPS) on post-viral airway disease is independent of the Type I interferon receptor von Resiliac, Jenny, Rohlfing, Michelle, Santoro, Jennifer, Hussain, Syed-Rehan A., Grayson, Mitchell

Volltext

Lipopolysaccharide (LPS) protects from severe respiratory paramyxoviral viral infection through an innate immune response von Resiliac, Jenny, Rohlfing, Michelle, Santoro, Jennifer, Hussain, Syed-Rehan, Grayson, Mitchell

Volltext

Low-Dose Lipopolysaccharide Protects from Lethal Paramyxovirus Infection in a Macrophage- and TLR4-Dependent Process von Resiliac, Jenny, Rohlfing, Michelle, Santoro, Jennifer, Hussain, Syed-Rehan A, Grayson, Mitchell H

Volltext

Atopic neutrophils prevent post-viral airway disease von Hussain, Syed-Rehan A, Rohlfing, Michelle, Resiliac, Jenny, Santoro, Jennifer, Peeples, Mark E., Garcin, Dominique, Grayson, Mitchell H

Volltext

Lipopolysaccharide (LPS) protects from a normally lethal dose of respiratory viral infection and affects post-airway disease in a dose dependent manner von Resiliac, Jenny, Rohlfing, Michelle, Santoro, Jennifer, Hussain, Syed-Rehan A, Grayson, Mitchell

Volltext

Dose dependency of lipopolysaccharide (LPS) mediated protection from lethal respiratory paramyxoviral infection von Resiliac, Jenny, Rohlfing, Michelle, Santoro, Jennifer, Hussain, Syed-Rehan, Grayson, Mitchell

Volltext

Pre-treatment with lipopolysaccharide (LPS) protects against a normally lethal respiratory viral infection von Resiliac, Jenny, Rohlfing, Michelle, Santoro, Jennifer, Hussain, Syed-Rehan A., Grayson, Mitchell H

Volltext

Atopic Neutrophils Prevent Postviral Airway Disease von Hussain, Syed-Rehan A., Rohlfing, Michelle, Resiliac, Jenny, Santoro, Jennifer, Peeples, Mark E., Garcin, Dominique, Grayson, Mitchell H.

Volltext

Pre-existing atopy protects against a lethal respiratory viral infection in an IgE independent fashion von Resiliac, Jenny, Rohlfing, Michelle, Santoro, Jennifer L., Hussain, Syed-Rehan A., Grayson, Mitchell H.

Volltext

Mouse Model of Sendai Virus-Induced Lung Disease von Resiliac, Jenny, Santoro, Jennifer, Hussain, Syed-Rehan A., Rohlfing, Michelle, Grayson, Mitchell H.

Volltext